MENU
BIO TECH

Biotech Grand Prix 2025

Standing up for solutions to society's problems
Biotechnology, healthcare, medicine, drug discovery, medical devices, research tools, etc.
We implement the technologies and thoughts of entrepreneurs and researchers in the biotech field into society together.
NEWS
【開催報告】バイオテックグランプリ2025：最優秀賞はPyrozymeが受賞 ―世界最高の耐熱性プロテアーゼによる新しい価値提供
2025/10/20 Biotech Grand Prix 2025: Grand Prize Won by Pyrozyme - New Value Provided by the World's Best Thermostable Protease
  • Biotech Grand Prix
バイオテックグランプリ2025 開催のお知らせ
2025/10/15 Biotech Grand Prix 2025 to be held
  • Grand Prix
  • News
  • Biotech Grand Prix
領域別TECH PLANTER 2025 パートナー、ファイナリスト決定のお知らせ -全国から集結した84チームのファイナリスト、45のパートナー企業と共に世界の課題解決に挑む-
2025/09/20 Announcement of TECH PLANTER 2025 Partners and Finalists by Domain - 84 finalist teams from across Japan, together with 45 partner companies, will take on the challenge of solving global issues.
  • Agritech Grand Prix
  • Ecotech Grand Prix
  • Grand Prix
  • Deep Tech Grand Prix
  • News
  • Biotech Grand Prix
  • Food Tech Grand Prix
  • Marintec Grand Prix
  • Lifetech Grand Prix
TECH PLANTER 2025 デモデイ開始のお知らせ -国境を超えた課題解決プロジェクトを集合体の知を持って挑む-
2025/09/13 Announcement of the start of TECH PLANTER 2025 Demo Day -Taking on cross-border problem-solving projects with collective knowledge
  • Agritech Grand Prix
  • Ecotech Grand Prix
  • Grand Prix
  • Deep Tech Grand Prix
  • News
  • Biotech Grand Prix
  • Food Tech Grand Prix
  • Marintec Grand Prix
  • Lifetech Grand Prix
ABOUT
point (e.g. of a statement)
Scientific and technological "seeds" are being created in universities, research institutes, and corporate laboratories, but it takes a lot of effort before they sprout into practical applications. The "Tech Planter," organized by LIVERNESS and its partners, is an ecosystem designed to serve as a planter to discover these seeds and help them sprout into business. The Biotech Grand Prix is a program aimed at discovering and fostering technology seeds and entrepreneurs in the real tech field (biotechnology, healthcare, medicine, drug discovery, medical devices, research tools, etc.).

Related Grand Prix :. List of Biotech Grand Prix
subject (of taxation, etc.)
  • Those who have a vision to change the world or improve the world based on the technological seeds in the real tech field and have a will to establish or develop a new business.
  • Individuals and teams are both welcome to participate, even before incorporation.
  • No limitation on the number of years of establishment, even if you are already a corporation. Even if you are close to mass production or PMF establishment, if you are planning to collaborate with partner companies, etc., it is acceptable.
Application Theme
Biotechnologies supporting the environment, energy, food, agriculture, medicine and health, etc.
Application period
Monday, December 2, 2024 - Friday, July 4, 2025 23:59
Screening Criteria
A panel of judges composed of LIVERNESS and its partners will review the following items
  1. 01novelty (patentability)
  2. 02feasibility
  3. 03Overseas Expansion Capabilities
  4. 04Are you going to change the world?
  5. 05passion
commendation
Grand Prize: (300,000 yen cash prize + right to receive 5 million yen business investment) 1
Corporate Prize: (200,000 yen) Approximately 10 prizes will be awarded.
SCHEDULE
12/2[MON]

Entry Start

this way (direction close to the speaker or towards the speaker)Please register as a member and fill out the web form to apply. We also hold information sessions at universities and on an individual basis to encourage determination to enter and to teach tips on how to prepare documents. Please feel free to contact us for more information.

6/7[SAT]

kickoff

RIVANES and its partners, as well as entered teams, will meet and mingle.
Business consultation and partnership development with each other will be available. Participation or lack of participation on the day of the event will not be considered.

7/4[FRI].

1st round: Application Screening

A panel of judges composed of LIVERNESS and its partners will review the documents.
You will be asked to submit information about your team, skills, passions, and vision for the future via web form and video.
All applicants will be notified of the screening results and provided with feedback on their applications.
In addition, individual interviews (also online) for presentation review will be conducted for those who wish to participate.

8monthfirst 10 days of month

Finalists determined

Interviews will be held for applicants who pass the document screening to brush up their presentations for the final round.
In addition, meetings can be set up with partner companies for the purpose of business consultation and developing partnerships.

10/18[SAT]

Biotech Grand Prix

The 12 finalist teams that pass the document screening will be screened for presentation.

10Month～

Cooperation Discussion

After the Demo Day, the contact point between the venture and LIBANES will continue to be open for discussions on commercialization.
We handle a wide range of start-up issues, from incorporation to prototype development, financing, R&D, and more.
In addition, collaborative matching between ventures and partner companies has become more active to support business development.

PARTNER
  • Astellas Pharma Inc.
  • Obayashi Corporation
  • Kyodo Printing Co.
  • Reishunkan Co-Creation Laboratory Co.
  • Sysmex Corporation
  • Sumitomo Rubber Industries, Ltd.
  • Soken Chemical Co.
  • Daikin Industries, Ltd.
  • Dai Nippon Printing Co.
ASSET
  1. ASSET01Riverness Communicator
  2. ASSET02Partners
  3. ASSET03Professional Supporter
  4. ASSET04superfactory group
SUPPORT
  1. SUPPORT01Organize the purpose and vision of starting a business
  2. SUPPORT02Brush up on your presentation
  3. SUPPORT03Providing opportunities for business company collaboration
  4. SUPPORT04Support for R&D and prototype development
  5. SUPPORT05Support for knowledge and IP strategies
  6. SUPPORT06finance
DEMO DAY
Grand Prix Name
Biotech Grand Prix 2025
Location
center of a garage (1-16-3 Yokogawa, Sumida-ku, Tokyo)
Date & Time
Saturday, October 18, 2025, 13:00-19:00
Application period
Monday, December 2, 2024 - Friday, July 4, 2025 23:59
Participation Target
Held on a closed, pre-registration basis (finalists, partner companies, professional supporters, Super Factory Group)
organizing
Leave a Nest Co., Ltd.
timeline
12:30-13:00
inauguration
13:00-13:30
Greetings from the Organizer
13:30-17:00
Presentation (Presenter①～⑫)
17:00-17:50
Review Time
17:50-19:00
Announcement of Judging Results and Award Ceremony
19:00-19:30
(cultural) exchange meeting
JUDGE
  • 髙橋 宏之
    head judge
    Director, Knowledge Foundation Research Center, Liverness, Inc.
    Hiroyuki Takahashi
    Since 2009, he has been involved in activities to create an entry point for social implementation of research results and ideas from academia, such as the launch of the "Liberace Research Grant," a private-sector-led research grant for researchers under 40 years of age, and the launch of the "Association for the Study of Ultra-Different Fields," an academic society that gathers knowledge from academia, venture companies, large corporations, and small factories in the town. He is also involved in activities to create an entry point for social implementation of research results and ideas from academia. He also serves as a director of NEST iPLAB, Inc.
  • 後藤 正英
    Head of Open Innovation Management, Astellas Pharma Inc.
    Masahide Goto
    He joined the former Yamanouchi Pharmaceuticals after receiving his degree in Biotechnology from Tokyo Institute of Technology in 1997. He was engaged in early drug discovery research mainly for metabolic diseases at the Institute for Molecular Medicine, studied at University of Wisconsin Madison in 2011, led biologics research as head of the Biologics Research Laboratory since 2016, and led gene Leads therapeutic related programs; leads overall cellular drug discovery as President of cellular medicine subsidiary in US Massachusetts from 2021; current position from April 2024; has been a member of the Board of Directors of the University of Wisconsin-Madison since 2011.
  • 赤川 宏幸
    General Manager, Future Technology Creation Department, Technology Division, Obayashi Corporation
    Hiroyuki Akagawa
    In 1993, he joined Obayashi Corporation. In 2023, he joined the Future Technology Creation Department to plan and collaborate on future visions in the five fields of space, mobility, biotechnology, climate tech, and future living. Aiming for synergy between different fields and the construction industry. D. in Engineering.
  • 佐々木 雄一
    General Manager, Innovation Promotion Department, Technology Development Division, Kyodo Printing Co.
    Yuichi Sasaki
    After graduating from university, he joined the company in 1995 and gained about 15 years of experience at a packaging materials manufacturing plant, starting as a manufacturing operator and improving quality and manufacturing efficiency. After working in packaging design at the Packaging Division of the head office, he was transferred to the Packaging Product Development Department of the Technology Development Division in 2012, where he successfully launched a newly developed product. After working in the Environmental Technology Development Department and the Technology Planning Department, he was transferred to the newly established Innovation Promotion Department in April 2025, where he is working on creating themes for new businesses that are not limited to existing business domains.
  • 間地 大輔
    Chief Executive Officer, Positive Age Management Division, Reishunkan Seiyaku Co.
    Daisuke Maji
    After completing his graduate studies in Pharmaceutical Sciences at Kyushu University in 2001, he joined Reishunkan Seiyaku Co. He led the world's first application of the self-healing protein "HSP" to cosmetics and the discovery of "Angptl2," the root cause of aging, and its original ingredient "Shiranui Chrysanthemum. After working as a pharmacist in the kampo business, he is currently responsible for new businesses such as "Positive Rhythm," which focuses on biological rhythms, and "The House of Reishunkan Pharmacy," which considers health from a living environment, and oversees everything from research to manufacturing and business development.
  • 吉田 智一
    Director, Managing Executive Officer, CTO, Sysmex Corporation
    Tomokazu Yoshida
    D. in Pharmaceutical Sciences from Okayama University in 1995. After engaging in drug discovery research at national research institutes and pharmaceutical companies, he joined Sysmex Corporation in 2000. He was involved in diagnostic principles and practical application research for cancer, chronic diseases, and central nervous system diseases, as well as clinical research at U.S. medical institutions. He has been a director of MEDICALOID Corporation, which was jointly established with Kawasaki Heavy Industries, Ltd. to promote the development and introduction of the medical robot "hinotori™". 2023-present: Director, Managing Executive Officer, CTO, responsible for R&D management.
  • 野尻 和紀
    Sumitomo Rubber Industries, Ltd.General Manager, Research Planning Dept.
    Kazunori Nojiri
    Born in 1978, he joined Sumitomo Rubber Industries, Ltd. in 2013. He is assigned to Research Department 3, Research and Development Division. He is engaged in the development of rubber rollers for electrophotography, medical rubber used in syringes, and high damping rubber for seismic dampers, etc. From January 2024, he has been promoting new businesses, including institutional design of new businesses, in the Research Planning Department, Research & Development Division.
  • 伊純 明寛
    Soken Chemical Co.Senior Technology Strategist, New Business Planning Department
    Akihiro Ijun
    After working in technology and business development of DDS formulations for pharmaceutical and medical device companies, he joined Soken Chemical Co. He is a graduate of the University of Wales Trinity Saint David (MBA) and a certified cell culturist from the Japanese Society of Tissue Culture. Certified Cell Culturist.
  • 歳清 公明
    Chief Engineer, Information and Communication Group Leader, Technology Innovation Center, Daikin Industries, Ltd.
    Year Kiyoshi Komei
    In 2003, after completing the doctoral program (engineering) at the Graduate School of Natural Science and Technology, Kobe University, he joined Matsushita Electric Industrial Co. In 2013, he was transferred to Silicon Valley, North America, as the head of new business, where he was engaged in marketing and solution development, In 2022, he joined Daikin Industries, where he is in charge of solution technology planning. Currently, he is promoting the early launch of new businesses within the company by simultaneously implementing technology development and business development in the cold chain field.
  • 菖蒲 弘人
    Senior Researcher, Food and Healthcare Business Development Unit, Business Development Division, R&D and Commercialization Promotion Center, Dai Nippon Printing Co.
    Hiroto Iris
    Graduated from Tokyo University of Science, Faculty of Science in 2002, engaged in research on biomaterials at Tokyo Medical and Dental University (now Tokyo University of Science), and obtained a Ph. Since joining DNP in 2008, he has been engaged in the development of regenerative medicine-related technologies. After working on joint development with Tokyo Medical and Dental University and Osaka University, he has been in his current position since 2022, promoting commercialization of regenerative medicine-related technologies. He also serves as the chairman of the Regenerative Medicine Innovation Forum: Entrepreneurship and Commercialization Promotion Committee.
FINALIST
  •  
    鈴木健吾
    Regenesome Corporation
    Representative] Kengo Suzuki
    老化による課題をバイオテクノロジーで解決する

    Biotechnology Solves the Challenges of Aging

    The RongevityTech business uses exosomes and other biotechnologies to solve health issues on Earth and in space due to aging.
  • TOMOWEL Kyodo Printing Award
    伊藤 健司
    Cellufilm Research Institute Co.
    Representative] Kenji Ito
    静置培養バッグ「OKUDAKE」

    OKUDAKE" static culture bag

    OKUDAKE, a static culture bag made of highly gas permeable film, enables static culture of microbial cultures that require aeration. By eliminating physical stress caused by shaking, it brings out the potential of cultures and expands the possibilities of biotechnology.
  • Sumitomo Rubber Award / DAIKIN Award
    大石俊輔
    Craftide Inc.
    Representative] Shunsuke Oishi
    ペプチドファーミングで拓く持続可能な農業

    Peptide Farming Opens the Door to Sustainable Agriculture

    Peptide Farming, which utilizes naturally degradable peptides, draws out the power of plants and applies it to agriculture. It contributes to the realization of environmentally harmonized agriculture by accelerating nutrient absorption and increasing tolerance to high temperatures and drought stress.
  •  
    岡田 隆彦
    Miyako Marker Institute, Inc.
    Representative] Takahiko Okada
    手の平サイズの尿検査器でヘルスケアの新概念の構築

    Building a New Concept in Health Care with a Palm-sized Urine Analyzer

    Urine discharges molecular markers that reflect the intestinal environment, natural immune cell activity, and mental status. We have developed a technology to measure these markers with a "small palm-sized testing device" and bring a new self-check tool for creating health to the world.
  • OBAYASHI - MAKE BEYOND Award
    照月 大悟
    Mos-Q
    Representative] TERUTSUKI Daigo
    蚊の嗅覚を活かすヒト臭センサで災害現場に挑む

    Challenging Disaster Sites with Human Odor Sensors that Utilize Mosquito Sense of Smell

    Develop a bio-hybrid odor sensor that applies the mosquito's sense of smell to detect human-specific odors with high sensitivity. The aim is to develop a new technology to locate people in need of rescue at disaster sites where image sensors do not work well, such as in poor visibility or under rubble, by using smell as a clue.
  • Grand Prize
    古賀 雄一
    Pyrozyme
    Representative] Yuichi Koga
    世界最高の耐熱性プロテアーゼによる新しい価値提供

    Providing new value with the world's best thermostable protease

    Proteins have unlimited possibilities, and based on mass production technology for proteases (proteolytic enzymes), which are rare enzymes that work even at 100°C, we are overturning the conventional wisdom that enzymes are weak against heat and realizing new manufacturing through "enzymatic reactions at 100°C".
  •  
    松﨑 千秋
    QualitiZyme
    Representative] Chiaki Matsuzaki
    リサイクルを可能にする高機能化酵素の作製技術

    Technology for producing highly functionalized enzymes that enable recycling

    Enzymes are needed for the manufacture of products in a variety of industries, including medicine, food, chemical industry, and agriculture. We are innovating the efficiency, cost, and environmental impact of manufacturing by making natural enzymes more functional (improved stability and functionality) so that they can be used industrially.
  •  
    中牟田 侑昌
    SoLAVi
    Representative] Yusho Nakamuta
    電気ウナギに学ぶ 生体適合型カーボン電池の開発

    Learning from Electric Eels Development of Biocompatible Carbon Battery

    Learning from the power-generating organs of electric eels, we are creating a new battery that does not use metals. The challenge is to develop next-generation batteries with biocompatibility, flexibility, and natural degradability in a layered hydrogel structure made of graphene oxide and bio-carbon, with an eye toward medical/wearable applications.
  • Soken Chemical Award / Real Tech Fund Award
    久保 拓也
    SPM Maneuver
    Representative] Takuya Kubo
    革新的分離剤：多様化モダリティ医薬品分離と精製

    Innovative Separants: Diversified Modality Pharmaceutical Separation and Purification

    The proprietary sponge monolith (SPM) has micron-sized through holes and is suitable as a separation field for new drug modalities. We aim to update this to the gold standard for pharmaceutical separation and build a new pharmaceutical production system.
  •  
    高橋 徹
    TerrAccel
    Representative] Toru Takahashi
    電子ビームで創るクリーンな未来、TerraQLean

    A Clean Future Created by Electron Beams, TerraQLean

    Applying superconducting acceleration technology for particle physics experiments and the International Linear Collider, we have developed an electron beam sterilizer that is 1/10th the size and 1/5th to 1/10th the price of conventional ones. It replaces ethylene oxide gas sterilization, which is feared to be environmentally destructive and carcinogenic, and realizes safe and secure medical treatment.
  •  
    藤井 創太郎
    gash
    Representative] Sotaro Fujii
    乳酸菌発酵による柑橘類残渣の再価値化

    Revalorization of Citrus Residues by Lactobacillus Fermentation

    To make effective use of the residue of citrus peels scheduled for disposal, we will develop fermentation technology using GABA high-producing lactic acid bacteria and aim to apply it as a new food material.
  • DNP Award
    高橋 賢
    physiola
    Representative] Ken Takahashi
    薬効毒性が見える！臓器チップを用いた未来医療

    Drug Toxicity Visible! Future medicine with organ chips

    The "skeleton twin" is a technology that makes each patient's drug response and toxicity risk transparent and reproduces the patient's response on a human organ chip as a digital twin. This technology will reduce medical costs and realize highly accurate and personalized medicine.